Summary:
A 5-year-old boy received CD34-positive HLA haplo-identical bone marrow transplantation from his father as treatment for refractory advanced neuroblastoma. He had residual disease in the para-aortic lymph nodes and multiple bones after the transplant. However, all of his residual disease had disappeared completely 3 years later. He developed grade I acute graft-versus-host disease (GVHD) but had no symptoms of chronic GVHD or any other complications. This case demonstrates the possibility of a graft-versus-tumor effect against neuroblastoma by HLA-mismatched allogeneic hematopoietic stem cell transplantation.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to the full article PDF.
USD 39.95
Prices may be subject to local taxes which are calculated during checkout


Similar content being viewed by others
References
Drobyski W, Keever C, Roth M et al. Salvage immunotherapy using donor leukocyte infusions as treatment for relapsed chronic myelogenous leukemia after allogeneic bone marrow transplantation: efficacy and toxicity of a defined T-cell dose. Blood 1993; 82: 2310–2318.
Childs R, Chernoff A, Contentin N et al. Regression of metastatic renal-cell carcinoma after nonmyeloablative allogeneic peripheral-blood stem-cell transplantation. N Engl J Med 2000; 343: 750–758.
Pedrazzoli P, Da Prada GA, Giorgiani G et al. Allogeneic blood stem cell transplantation after a reduced-intensity, preparative regimen: a pilot study in patients with refractory malignancies. Cancer 2002; 94: 2409–2415.
Kaneko M, Tsuchida Y, Uchino J et al. Treatment results of advanced neuroblastoma with the first Japanese study group protocol. J Pediatr Hematol Oncol 1999; 21: 190–197.
Matthay KK, Villablanca JG, Seeger RC et al. Treatment of high-risk neuroblastoma with intensive chemotherapy, radiotherapy, autologous bone marrow transplantation, and 13-cis-retinoic acid, Children's Cancer Group. N Engl J Med 1999; 341: 1165–1173.
Kawa-Ha K, Yumura-Yagi K, Inoue M et al. Results of single and double autografts for high-risk neuroblastoma patients. Bone Marrow Transplant 1996; 17: 957–962.
Yasui M, Park YD, Okamura T et al. CD34+ progenitor cell transplantation from two HLA-mismatched healthy fathers to two infants with severe aplastic anemia. Int J Hematol 1998; 67: 15–22.
Kato S, Yabe H, Yasui M et al. Allogeneic hematopoietic transplantation of CD34+ selected cells from an HLA haplo-identical related donor. A long-term follow-up of 135 patients and a comparison of stem cell source between the bone marrow and the peripheral blood. Bone Marrow Transplant 2000; 26: 1281–1290.
Negrier S, Michon J, Floret D et al. Interleukin-2 and lymphokine-activated killer cells in 15 children with advanced metastatic neuroblastoma. J Clin Oncol 1991; 9: 1363–1370.
Matthay KK, Seeger RC, Reynolds CP et al. Allogeneic versus autologous purged bone marrow transplantation for neuroblastoma: a report from the Children's Cancer Group. J Clin Oncol 1994; 12: 2382–2389.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Inoue, M., Nakano, T., Yoneda, A. et al. Graft-versus-tumor effect in a patient with advanced neuroblastoma who received HLA haplo-identical bone marrow transplantation. Bone Marrow Transplant 32, 103–106 (2003). https://doi.org/10.1038/sj.bmt.1704070
Received:
Accepted:
Published:
Issue date:
DOI: https://doi.org/10.1038/sj.bmt.1704070
Keywords
This article is cited by
-
αβ T-cell-depleted haploidentical hematopoietic cell transplantation and zoledronate/interleukin-2 therapy in children with relapsed, high-risk neuroblastoma
Bone Marrow Transplantation (2019)
-
Early immunisation with dendritic cells after allogeneic bone marrow transplantation elicits graft vs tumour reactivity
British Journal of Cancer (2013)
-
Allogeneic hematopoietic cell transplantation for neuroblastoma: the CIBMTR experience
Bone Marrow Transplantation (2013)
-
Engraftment of unrelated cord blood after reduced-intensity conditioning regimen in children with refractory neuroblastoma: a feasibility trial
Bone Marrow Transplantation (2011)
-
Successful tandem (autologous-cord blood) SCT in advanced neuroblastomas with highly amplified MYCN
Bone Marrow Transplantation (2011)


